XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $71,724,249 | -0.3% | 1,839,555 | +10.0% | 0.13% | -2.2% |
| Q1 2024 | $71,976,027 | +49.0% | 1,671,917 | +59.4% | 0.14% | +36.0% |
| Q4 2023 | $48,304,274 | +157.1% | 1,048,725 | +90.7% | 0.10% | +132.6% |
| Q3 2023 | $18,788,000 | -27.2% | 550,000 | -17.9% | 0.04% | -23.2% |
| Q2 2023 | $25,795,000 | -3.9% | 670,000 | -10.7% | 0.06% | -6.7% |
| Q1 2023 | $26,842,500 | -6.1% | 750,000 | +3.4% | 0.06% | -11.8% |
| Q4 2022 | $28,586,750 | +17.3% | 725,000 | +7.4% | 0.07% | +13.3% |
| Q3 2022 | $24,368,000 | +27.1% | 675,000 | +7.1% | 0.06% | +36.4% |
| Q2 2022 | $19,165,000 | -3.6% | 630,000 | -3.1% | 0.04% | +15.8% |
| Q1 2022 | $19,871,000 | -4.4% | 650,000 | -2.3% | 0.04% | +2.7% |
| Q4 2021 | $20,775,000 | +15.7% | 665,000 | -43.4% | 0.04% | +5.7% |
| Q3 2021 | $17,954,000 | -36.8% | 1,175,000 | -23.0% | 0.04% | -37.5% |
| Q2 2021 | $28,396,000 | -37.8% | 1,525,000 | -40.2% | 0.06% | -39.8% |
| Q1 2021 | $45,645,000 | +21.1% | 2,550,000 | +4.1% | 0.09% | +13.4% |
| Q4 2020 | $37,681,000 | +38.9% | 2,450,000 | 0.0% | 0.08% | +20.6% |
| Q3 2020 | $27,122,000 | +6.8% | 2,450,000 | +21.0% | 0.07% | +4.6% |
| Q2 2020 | $25,394,000 | +10.6% | 2,025,000 | 0.0% | 0.06% | -5.8% |
| Q1 2020 | $22,964,000 | -9.0% | 2,025,000 | +5.2% | 0.07% | +11.3% |
| Q4 2019 | $25,237,000 | +115.5% | 1,925,000 | +48.1% | 0.06% | +113.8% |
| Q3 2019 | $11,713,000 | -8.6% | 1,300,000 | 0.0% | 0.03% | -9.4% |
| Q2 2019 | $12,818,000 | -3.0% | 1,300,000 | 0.0% | 0.03% | -3.0% |
| Q1 2019 | $13,208,000 | +61.0% | 1,300,000 | 0.0% | 0.03% | +43.5% |
| Q4 2018 | $8,203,000 | -48.2% | 1,300,000 | +8.3% | 0.02% | -34.3% |
| Q3 2018 | $15,840,000 | +115.2% | 1,200,000 | +50.0% | 0.04% | +105.9% |
| Q2 2018 | $7,360,000 | – | 800,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |